首页> 外文OA文献 >The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

【2h】

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

机译：DNA甲基转移酶抑制剂，GuadeCitabine，靶向肿瘤诱导的髓鞘，并恢复T细胞活性，以缓慢肿瘤生长与乳腺癌小鼠模型中的养护免疫疗法组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andrea J. Luker; Laura J. Graham; Timothy M. Smith; Carmen Camarena; Matt P. Zellner; Jamie-Jean S. Gilmer; Sheela R. Damle; Daniel H. Conrad; Harry D. Bear; Rebecca K. Martin;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer [J] . Andrea J. Luker, Laura J. Graham, Timothy M. Smith, BMC Immunology . 2020,第1期

机译：DNA甲基转移酶抑制剂，GuadeCitabine，靶向肿瘤诱导的髓鞘，并恢复T细胞活性，以缓慢肿瘤生长与乳腺癌小鼠模型中的养护免疫疗法组合
2. 549 POSTER The RANKL inhibitor osteoprotegerin (OPG) inhibits tumor growth, prevents tumor-induced osteolysis, and significantly improves survival in a mouse model of breast cancer bone metastasis [J] . J.Canon, M.Roudier, R.Bryant, European Journal of Cancer Supplements . 2006,第12期

机译：549海报RANKL抑制剂骨保护素（OPG）抑制肿瘤的生长，防止肿瘤引起的骨溶解，并显着提高乳腺癌骨转移小鼠模型的存活率
3. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer [J] . ChenM., ShabashviliD., NawabA., Molecular cancer therapeutics . 2012,第2期

机译：DNA甲基转移酶抑制剂zebularine在基因改造的乳腺癌小鼠模型中延迟肿瘤生长并诱导细胞凋亡
4. Evaluation of Antitumor Activity of Doxorubicin-Loaded Triblock Micelles in 3-D Multicellular Spheroids and Tumor-bearing Mouse Models for Cancer Chemotherapy [C] . T.H.Kim, C. Mount, T. Goodman, Annual meeting exposition of the Controlled Release Society . 2010

机译：阿霉素三嵌段胶束在3-D多细胞球体和荷瘤小鼠模型中的抗癌活性的癌症化疗的评价。
5. Drug Combination Nanoparticles Targeted to ICAM-1 on Breast Cancer Cells Enhance Cellular Drug Exposure in vitro and in Mouse Model [D] . Zhu, Linxi. 2021

机译：靶向ICAM-1对乳腺癌细胞的药物组合纳米颗粒增强了体外和小鼠模型的细胞药物暴露
6. The DNA methyltransferase inhibitor guadecitabine targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer [O] . Andrea J. Luker, Laura J. Graham, Timothy M. Smith, 2020

机译：DNA甲基转移酶抑制剂guadecitabine可靶向肿瘤诱导的骨髓生成并在乳腺癌小鼠模型中与过继免疫疗法相结合恢复T细胞活性以减缓肿瘤生长
7. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer [O] . Andrea J Luker, Laura J Graham, Matthew P Zellner, 2019

机译：DNA甲基转移酶抑制剂，GuadeCitabine，靶向肿瘤诱导的髓鞘，并恢复T细胞活性，以缓慢肿瘤生长与乳腺癌小鼠模型中的养护免疫疗法组合
8. Adoptive Immunotherapy for Epithelial Ovarian Cancer Using T-cells Simultaneously Targeted to Tumor and Tumor-Associated Macrophages. [R] . Maher, J., Ghaem-Maghami, S. 2013

机译：上皮性卵巢癌的过继免疫治疗使用T细胞同时针对肿瘤和肿瘤相关的巨噬细胞。

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅